These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9914603)

  • 21. [Association between amniotic fluid insulin in the second trimester, maternal glucose tolerance and fetal malformations].
    Bühling KJ; Mönnich J; Henrich W; Brauer M; Heinze T; Siebert G; Dudenhausen JW
    Z Geburtshilfe Neonatol; 2004 Dec; 208(6):226-31. PubMed ID: 15647986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.
    Park CW; Park JS; Shim SS; Jun JK; Yoon BH; Romero R
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):984-9. PubMed ID: 16157098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association of second trimester biomarkers in amniotic fluid and fetal outcome.
    Sterpu I; Anfelter P; Wray S; Kaihola H; Åkerud H; Wiberg-Itzel E
    J Matern Fetal Neonatal Med; 2019 Nov; 32(21):3627-3632. PubMed ID: 29685073
    [No Abstract]   [Full Text] [Related]  

  • 24. In pregnancy, corticotropin-releasing-factor in maternal blood and amniotic fluid correlates with the gestational age.
    Maser-Gluth C; Lorenz U; Vecsei P
    Horm Metab Res Suppl; 1987; 16():42-4. PubMed ID: 3502115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Midtrimester amniotic fluid concentrations of angiogenic factors in relation to maternal, gestational and neonatal characteristics in normal pregnancies.
    Papapostolou T; Briana DD; Boutsikou M; Iavazzo C; Puchner KP; Gourgiotis D; Marmarinos A; Malamitsi-Puchner A
    J Matern Fetal Neonatal Med; 2013 Jan; 26(1):75-8. PubMed ID: 22963269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoreactive corticotropin-releasing hormone in amniotic fluid.
    Sasaki A; Shinkawa O; Yoshinaga K
    Am J Obstet Gynecol; 1990 Jan; 162(1):194-8. PubMed ID: 2301493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feto-placental hypoxemia regulates the release of fetal activin A and prostaglandin E(2).
    Jenkin G; Ward J; Hooper S; O'Connor A; de Kretser D; Wallace E
    Endocrinology; 2001 Feb; 142(2):963-6. PubMed ID: 11159871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The assessment of the relationship between amniotic fluid matrix metalloproteinase-9 and zinc levels with adverse obstetric outcomes.
    Ozdamar O; Gün I; Müngen E; Atay V
    Arch Gynecol Obstet; 2014 Jul; 290(1):59-64. PubMed ID: 24573505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated monocyte chemotactic protein-1 in amniotic fluid is a risk factor for pregnancy loss.
    Chaiworapongsa T; Romero R; Tolosa JE; Yoshimatsu J; Espinoza J; Kim YM; Kim JC; Bujold E; Kalache K; Edwin S
    J Matern Fetal Neonatal Med; 2002 Sep; 12(3):159-64. PubMed ID: 12530612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amniotic fluid and umbilical cord serum erythropoietin in term and prolonged pregnancies.
    Seikku L; Stefanovic V; Rahkonen P; Teramo K; Paavonen J; Tikkanen M; Rahkonen L
    Eur J Obstet Gynecol Reprod Biol; 2019 Feb; 233():1-5. PubMed ID: 30529256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokines in noninvasively obtained amniotic fluid as predictors of fetal inflammatory response syndrome.
    Kunze M; Klar M; Morfeld CA; Thorns B; Schild RL; Markfeld-Erol F; Rasenack R; Proempeler H; Hentschel R; Schaefer WR
    Am J Obstet Gynecol; 2016 Jul; 215(1):96.e1-8. PubMed ID: 26829512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clara cell protein 16 concentration in mid-trimester amniotic fluid: association with fetal gender, fetal G>A +38 CC16 gene polymorphism and pregnancy outcome.
    Perni SC; Vardhana S; Kalish R; Chasen S; Witkin SS
    J Reprod Immunol; 2005 Dec; 68(1-2):85-90. PubMed ID: 16236364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Second-trimester amniotic fluid interleukin-10 concentration predicts preterm delivery.
    Apuzzio J; Chan Y; Al-Khan A; Illsley N; Kim PL; Vonhaggen S
    J Matern Fetal Neonatal Med; 2004 May; 15(5):313-7. PubMed ID: 15280122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting outcomes of emergency cerclage in women with cervical insufficiency using inflammatory markers in maternal blood and amniotic fluid.
    Jung EY; Park KH; Lee SY; Ryu A; Joo JK; Park JW
    Int J Gynaecol Obstet; 2016 Feb; 132(2):165-9. PubMed ID: 26553528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin 16 in pregnancy, parturition, rupture of fetal membranes, and microbial invasion of the amniotic cavity.
    Athayde N; Romero R; Maymon E; Gomez R; Pacora P; Yoon BH; Edwin SS
    Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):135-41. PubMed ID: 10649168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistin in mid-trimester amniotic fluid in trisomy 21.
    Vrachnis N; Gkogkas L; Iliodromiti S; Grigoriadis C; Samoli E; Iliodromiti Z; Pangalos C; Pappa KI; Drakoulis N; Creatsas G; Botsis D
    J Matern Fetal Neonatal Med; 2013 Nov; 26(16):1576-80. PubMed ID: 23544842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiogenin: a marker for preterm delivery in midtrimester amniotic fluid.
    Spong CY; Ghidini A; Sherer DM; Pezzullo JC; Ossandon M; Eglinton GS
    Am J Obstet Gynecol; 1997 Feb; 176(2):415-8. PubMed ID: 9065191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amniotic fluid concentrations of collagenase-1 and collagenase-3 are increased in polyhydramnios.
    Fortunato SJ; Menon R; Ahmed NU; Bourgeois M; Dildy GA
    J Perinat Med; 2004; 32(2):122-5. PubMed ID: 15085886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Total antioxidant capacity and reactive oxygen species in amniotic fluid.
    Burlingame JM; Esfandiari N; Sharma RK; Mascha E; Falcone T
    Obstet Gynecol; 2003 Apr; 101(4):756-61. PubMed ID: 12681882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ovine allantoic fluid contains high concentrations of activin A: partial dissociation of immunoactivity and bioactivity.
    Foulds LM; de Kretser DM; Farnworth P; Buttress D; Jenkin G; Groome NP; McFarlane JR
    Biol Reprod; 1998 Aug; 59(2):233-40. PubMed ID: 9687290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.